Top

21-03-2018 | Vasculitis | Review | Article

Vasculitis in Africa

Journal: Current Rheumatology Reports

Authors: Eugene Genga, Omondi Oyoo, Adewale Adebajo

Abstract

Purpose of Review

Systemic vasculitides are characterized by inflammation of blood vessel walls leading to a myriad of organ disorders depending on the size, site, and location of the affected blood vessel. The epidemiology of vasculitis in the developing world has been inadequately documented. The description of the vasculitides in Africa, both from hospital series as well as taking into consideration, previous epidemiological studies in the community, indicates that these conditions have been rare until relatively recently. In view of these past observations, this review of publications on the topic looks to shed light on the current state of vasculitis in Africa.

Recent Findings

Takayasu and Kawasaki appear to be the most commonly reported vasculitides in Africa. Most of the published reports are from North and South Africa. Furthermore, the contribution of vasculitis associated with infections, and in particular HIV, is significant.

Summary

There are increasing numbers of publications reflecting a growing recognition of the vasculitides in Africa.

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. https://doi.org/10.1002/art.37715.CrossRefPubMed

Watts RA, Scott DG. Epidemiology of vasculitis. In: Ball GV, Fessler BJ, Bridges SL, editors. Oxford textbook of vasculitis. 3rd ed. Oxford: Oxford University Press; 2014. p. 7–28. https://doi.org/10.1093/med/9780199659869.003.0002.

Ghannouchi JN, Khalifa M, Rezgui A, Alaoua A, Ben JE, Braham A, et al. Takayasu disease in Central Tunisia, 27 cases. J Mal Vasc. 2010;35(1):4–11.CrossRef

Kechaou M, Frigui M, Ben Hmida M, Bahloul Z. Takayasu arteritis in Southern Tunisia a study of 29 patients. Presse Med. 2009;38(10):1410–4. https://doi.org/10.1016/j.lpm.2008.10.023.CrossRefPubMed

Elasri A, Tazi-Mezalek Z, Aouni M, Adnaoui M, Mohattane A, Bensaid Y, et al. Takayasu’s disease in Morocco. Report of 47 cases. Rev Med Interne. 2002;23(1):9–20.

• Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005;75(3):110–7. https://doi.org/10.1111/j.1445-2197.2005.03312.x. This study provides the largest case review on Takayasu in Africa.

Guidozzi F, Louridas G, Grant MG, Koller AB, King P, Naylor S. Takayasu’s arteritis in a pregnant woman. A case report. S Afr J Surg. 1991;29(4):159–60.PubMed

Oguntona S A. Takayasu's disease in a young black boy. Niger J Clin Pract 2010;13:467–9.PubMed

Ndongo S, Diallo S, Tiendrebeogo J, Diop IB, Tall A, Pouye A, et al. Systemic vasculitis: study of 27 cases in Senegal. Med Trop (Mars). 2010;70(3):264–6.

10.

Fielder JFA. 23-year-old woman admitted to Kijabe Mission Hospital with bilateral lower extremity gangrene. MedGenMed. 2004;6:56.PubMedPubMedCentral

11.

Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983;26(10):1214–9. https://doi.org/10.1002/art.1780261007.CrossRefPubMed

12.

Gonzalez EB, Varner WT, Lisse JR, Daniels JC, Hokanson JA. Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med. 1989;149(7):1561–5. https://doi.org/10.1001/archinte.1989.00390070087012.CrossRefPubMed

13.

• Khalifa M, Karmani M, Ghannouchi J, The Study Group of GCA in Tunisia. Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med. 2009. This study is the first large case review on GCA in Africa.;20(2):208–12. https://doi.org/10.1016/j.ejim.2008.07.030.

14.

•• Lamloum M, Ben Salem T, Molka T, Ben Salem W, et al. Giant cell arteritis in Tunisia demographic, clinical and laboratory characteristics: analysis of 90 patients. Poster presentations / Eur Geriatr Med. 2015;6S1:S32–S156. This study provides the most recent data on GCA in Africa

15.

El-Sayed ZA, El-Awady HM, Hassan ZE, Adham TMH, Mostafa HM, Elhefnawy NG. Giant cell arteritis in a 12-year-old girl presenting with nephrotic syndrome. Case Rep Rheumatol. 2014;2014:491937, 4 pages. https://doi.org/10.1155/2014/491937.PubMedPubMedCentral

16.

Admassu F, Mitku Y, Tesfaye W. Giant cell arteritis: a report of two cases from Ethiopia. J Clin Exp Ophthalmol. 2016;7(05):598. https://doi.org/10.4172/2155-9570.1000598.CrossRef

17.

Gorrab AA, Fournier A, Bouaziz AA, et al. Incidence rate and epidemiological and clinical aspects of Kawasaki disease in children of Maghrebi origin in the province of Quebec, Canada, compared to the country of origin. Glob Pediatr Health. 2016;3:2333794X16630670. https://doi.org/10.1177/2333794X16630670.PubMedPubMedCentral

18.

•• Boudiaf H, Achir M. The clinical profile of Kawasaki disease in Algerian children: a single institution experience. J Trop Pediatr. 2016;62(2):139–43. https://doi.org/10.1093/tropej/fmv090. This study is the largest documented audit on Kawasaki disease in Africa. CrossRefPubMed

19.

Rizk SR, El Said G, Daniels LB, et al. Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood. Am J Cardiol. 2015;115(4):423–7. https://doi.org/10.1016/j.amjcard.2014.11.024.CrossRefPubMed

20.

Mabiala Babela JR, Ollandzobo Ikobo LC, Nika RE, Moyen G. Study of 11 new cases of Kawasaki disease Congolese. Bull Soc Pathol Exot. 2015;108(4):250–4. https://doi.org/10.1007/s13149-015-0445-2.CrossRefPubMed

21.

Migowa A, Colmegna I, Hitchon C, Were E, Ng’ang’a E, Ngwiri T, et al. The spectrum of rheumatic in-patient diagnoses at a pediatric hospital in Kenya. Pediatr Rheumatol Online J. 2017;15(1):4. https://doi.org/10.1186/s12969-016-0131-3.

22.

Animasahun A, Adekunle M, Kusimo O, Fadipe C. The diagnosis of Kawasaki disease among Nigerian children: a nightmare for the caregivers and the doctors. J Public Health Emerg. 2017;1(7).

23.

Badoe EV, Neequaye J, Oliver-Commey JO, Amoah J, Osafo A, Aryee I, et al. Kawasaki disease in Ghana: case reports from Korle Bu Teaching Hospital. Ghana Med J. 2011;45(1):38–42.

24.

Sani UM, Ahmed H. Kawasaki disease: an unusual presentation in a 14-year old boy in Sokoto, north western Nigeria. Niger J Paediatr. 2013;40(4):422–5. https://doi.org/10.4314/njp.v40i4.15.CrossRef

25.

Eno-Obong EU, Mkpouto UA. Kawasaki disease in a two-year-old Nigerian child: full recovery with supportive treatment. Ibom Med J. 2014;7:40–4.

26.

Rakotovao DN, Miandrisoa RM, Ramanitrarivo VL, Rakotonirina G, Rakotomamonjy SP, Imbert P. Kawasaki disease: a case report from Madagascar. Med Trop (Mars). 2008;68(6):637–9.

27.

Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014;48–49:84–9.CrossRefPubMed

28.

McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology. 1989;9(1):97–101. https://doi.org/10.1002/hep.1840090116.CrossRefPubMed

29.

Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51(1):92–9. https://doi.org/10.1002/art.20077.CrossRefPubMed

30.

•• Borkhum M et al. Polyarteritis nodosa presenting as a bladder outlet obstruction. S Afr Med J. 2016;106(11):1086–1087. ISSN 2078-5135. This is the only case report of PAN from Africa. https://doi.org/10.7196/SAMJ.2016.v106i11.11083.

31.

• Ben Ghorbel I, Belfeki N, Baouandi N, et al. Granulomatosis with polyangiitis in Tunisia. Description of 21 cases. Ann Rheum Dis. 2013;72:A928. A comprehensive review of ANCA-associated vasculitis in Africa. CrossRef

32.

•• Ben Ghorbel I, Belfeki N, Baouendi N, Ben Salem T, Houman MH. Granulomatosis with polyangiitis in Tunisia. Reumatismo. 2017;69(1):23–29. ISSN 2240-2683. The most recent report of ANCA-associated vasculitis in Africa. https://doi.org/10.4081/reumatismo.2017.935.

33.

Penny K, Fleming M, Kazmierczak D, Thomas A. An epidemiological study of Henoch-Schonlein purpura. Paediatr Nurs. 2010;22(10):30–5. https://doi.org/10.7748/paed.22.10.30.s27.CrossRefPubMed

34.

Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, et al. A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology (Oxford). 2005;44(5):618–22. https://doi.org/10.1093/rheumatology/keh544.

35.

Aalberse J, Dolman K, Ramnath G, Pereira RR, Davin JC. Henoch Schonlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann Rheum Dis. 2007;66(12):1648–50. https://doi.org/10.1136/ard.2006.069187.CrossRefPubMedPubMedCentral

36.

Dolezalova P, Telekesova P, Nemcova D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol. 2004;31(11):2295–9.PubMed

37.

Naija O, Bouzaraa J, Goucha-Louzir R, Lakhoua MR. Predictive factors of severe Henoch-Schonlein nephritis in children: report of 34 cases. Tunis Med. 2012;90(12):878–81.PubMed

38.

Maaloul I, Sfaihi L, Telmoudi J, et al. PO-0016 Henoch Scholein purpura in children: about 24 cases. Arch Dis Child. 2014;99:A256.CrossRef

39.

Salah, et al. MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura. Pediatr Rheumatol. 2014;12(1):41. https://doi.org/10.1186/1546-0096-12-41.CrossRef

40.

Aatif T, Maoujoud O, Montasser DI, Benyahia M, Oualim Z. Glomerular diseases in the Military Hospital of Morocco: review of a single centre renal biopsy database on adults. Indian J Nephrol. 2012;22(4):257–63. https://doi.org/10.4103/0971-4065.101244.CrossRefPubMedPubMedCentral

41.

Souilmi FZ, Houssaini TS, Alaoui H, Harmouch T, Atmani S, Hida M. Indications and results of renal biopsy in children: a single-center experience from Morocco. Saudi J Kidney Dis Transpl. 2015;26(4):810–5. https://doi.org/10.4103/1319-2442.160225.CrossRefPubMed

42.

Hammami S, Nasr M, Sassi N, et al. AB0365 Henoch-schÖnlein purpura in Tunisian adults: monocentric study. Ann Rheum Dis. 2017;76:1176.CrossRef

43.

Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol. 2007;26(4):555–60. https://doi.org/10.1007/s10067-006-0349-4.

44.

Ndiaye M, Sow AS, Valiollah A, Diallo M, Diop A, Alaoui RA, et al. Behçet’s disease in black skin. A retrospective study of 50 cases in Dakar. J Dermatol Case Rep. 2015;9(4):98–102. https://doi.org/10.3315/jdcr.2015.1213.

45.

Liozon E, Roussin C, Puechal X, et al. Behçet’s disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine. 2011;78(2):166–70. https://doi.org/10.1016/j.jbspin.2010.05.007.CrossRefPubMed

46.

•• Houman MH, Neffati H, Braham A, Harzallah O, Khanfir M, Miled M, et al. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol. 2007;25(4 Suppl 45):S58–64. This study is the largest documented cohort of Behçet’s disease in Africa.

47.

Wang H, Wolock T, Carter A, Nguyen G, Kyu H, Gakidou E, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3(8):e361–87. ISSN 2352-3018. https://doi.org/10.1016/s2352-3018(16)30087-x.

48.

Brand M, Woodiwiss AJ, Michel F, Nayler S, Veller MG, Norton GR. Large vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infection. PLoS One. 2014;9(8):e106205. https://doi.org/10.1371/journal.pone.0106205.CrossRefPubMedPubMedCentral

49.

•• Robbs JV, Paruk N. Management of HIV vasculopathy—a South African experience. Eur J Vasc Endovasc Surg. 2010;39(Suppl 1):S25–31. https://doi.org/10.1016/j.ejvs.2009.12.028. A comprehensive review of HIV vasculopathy from South Africa. CrossRefPubMed

50.

Otedo AEO, Oyoo GO, Obondi JO, et al. Vasculitis in HIV: report of eight cases. East Afr Med J. 2005;82(12):656–9.PubMed

Medicine Matters Rheumatology

Abstract

Purpose of Review

Recent Findings

Summary